Obsessive Compulsive Disorder clinical trials

Explore recruiting obsessive compulsive disorder clinical trials.

Recruiting obsessive compulsive disorder studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Obsessive Compulsive Disorder trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Trial of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2a trial to evaluate the efficacy and safety of BP1.4979 in adult participants with obsessive compulsive disorder

Portugal, Spain, Italy, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Long-Term Open-Label Safety Study of Adjunctive Troriluzole in Subjects with Obsessive Compulsive Disorder

Italy, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Safety and Efficacy of Pramipexole Treatment in Resistant Obsessive-Compulsive Disorder (OCD): Pilot, Randomized and Controlled Clinical Trial

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blinded, placebo-controlled study of Rituximab in patients with Psychosis and/or Obsessive Compulsive Disorder, with an indication of immune system involvement.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Obsessive Compulsive Disorder trials by city

Obsessive Compulsive Disorder in Toronto Obsessive Compulsive Disorder in Vancouver Obsessive Compulsive Disorder in Montreal Obsessive Compulsive Disorder in Calgary Obsessive Compulsive Disorder in Edmonton Obsessive Compulsive Disorder in Ottawa Obsessive Compulsive Disorder in Winnipeg Obsessive Compulsive Disorder in Quebec City Obsessive Compulsive Disorder in Hamilton Obsessive Compulsive Disorder in Kitchener Obsessive Compulsive Disorder in London Obsessive Compulsive Disorder in Halifax Obsessive Compulsive Disorder in New York Obsessive Compulsive Disorder in Los Angeles Obsessive Compulsive Disorder in Chicago Obsessive Compulsive Disorder in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease